Methyl iodide → 6-(2,6-Dimethoxyphenyl)-3-methyl-1-(4-(trifluoromethoxy)benzyl)piperidin-2-one

HRID 594630Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 594630
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[C:5]([O:9][CH3:10])[C:4]=1[CH:11]1[N:16]([CH2:17][C:18]2[CH:23]=[CH:22][C:21]([O:24][C:25]([F:28])([F:27])[F:26])=[CH:20][CH:19]=2)[C:15](=[O:29])[CH2:14][CH2:13][CH2:12]1.I[CH3:31]>>[CH3:1][O:2][C:3]1[CH:8]=[CH:7][CH:6]=[C:5]([O:9][CH3:10])[C:4]=1[CH:11]1[N:16]([CH2:17][C:18]2[CH:23]=[CH:22][C:21]([O:24][C:25]([F:27])([F:26])[F:28])=[CH:20][CH:19]=2)[C:15](=[O:29])[CH:14]([CH3:31])[CH2:13][CH2:12]1

Komponenten

3

Edukt 2

HCID 6328Methyl iodideHCID 690817176-(2,6-Dimethoxyphenyl)-1-(4-(trifluoromethoxy)benzyl)piperidin-2-one

Produkt 1

HCID 690816426-(2,6-Dimethoxyphenyl)-3-methyl-1-(4-(trifluoromethoxy)benzyl)piperidin-2-one

Versuchsvorschrift

Prepared according to the described general procedure 8 (GP8) by C-alkylation of 6-(2,6-dimethoxyphenyl)-1-(4-(trifluoromethoxy)benzyl)piperidin-2-one with commercially available iodomethane. Subsequent purification by preparative HPLC afforded the target compound. LC-MS (conditions E): tR=0.84 min.; [M+H]+: 424.22 g/mol.

Aufarbeitung

  1. customPrepared
  2. customSubsequent purification by preparative HPLC
  3. customafforded the target compound

Quellen und Nachweise

ORD-Eintrag
ord-d72407b5db674f44911aa963d9a441ae
Quelldatensatz
uspto-grants-2016_01
Patentnummer
US09242970B2

Notizen zur Reaktion

Wird geladen…